175 related articles for article (PubMed ID: 31356093)
1. Tabari Cohort Profile and Preliminary Results in Urban Areas and Mountainous Regions of Mazandaran, Iran.
Kheradmand M; Moosazadeh M; Saeedi M; Poustchi H; Eghtesad S; Esmaeili R; Alizadeh-Navaei R; Hedayatizadeh-Omran A; Nikaeein R; Rafiei A; Janbabaee G; Kashi Z; Sohrab M; Shirzad AhooDashti M; Afshari M; Golpour B; Aarabi M; Maleki I; Tirgar Fakheri H; Ghaemian A; Zarghami M; Ghaemi A
Arch Iran Med; 2019 Jun; 22(6):279-285. PubMed ID: 31356093
[TBL] [Abstract][Full Text] [Related]
2. The PERSIAN Guilan Cohort Study (PGCS).
Mansour-Ghanaei F; Joukar F; Naghipour MR; Sepanlou SG; Poustchi H; Mojtahedi K; Balou HA; Heidarzadeh A; Malekzadeh R
Arch Iran Med; 2019 Jan; 22(1):39-45. PubMed ID: 30821159
[TBL] [Abstract][Full Text] [Related]
3. Non-communicable diseases in the southwest of Iran: profile and baseline data from the Shahrekord PERSIAN Cohort Study.
Ahmadi A; Shirani M; Khaledifar A; Hashemzadeh M; Solati K; Kheiri S; Sadeghi M; Mohammadian-Hafshejani A; Shahraki HR; Asgharzadeh A; Salehifard AZ; Mousavi M; Zarean E; Goujani R; Nazari SSH; Poustchi H; Dugué PA
BMC Public Health; 2021 Dec; 21(1):2275. PubMed ID: 34903205
[TBL] [Abstract][Full Text] [Related]
4. The profile of Rafsanjan Cohort Study.
Hakimi H; Ahmadi J; Vakilian A; Jamalizadeh A; Kamyab Z; Mehran M; Malekzadeh R; Poustchi H; Eghtesad S; Sardari F; Soleimani M; Khademalhosseini M; Abolghasemi M; Mohammadi M; Sadeghi T; Ayoobi F; Abbasi M; Mohamadi M; Jalali Z; Shamsizadeh A; Esmaeili-Nadimi A
Eur J Epidemiol; 2021 Feb; 36(2):243-252. PubMed ID: 32725579
[TBL] [Abstract][Full Text] [Related]
5. The protocol of a population-based prospective cohort study in southwest of Iran to analyze common non-communicable diseases: Shahrekord cohort study.
Khaledifar A; Hashemzadeh M; Solati K; Poustchi H; Bollati V; Ahmadi A; Kheiri S; Samani KG; Banitalebi M; Sedehi M; Malekzadeh R
BMC Public Health; 2018 May; 18(1):660. PubMed ID: 29801446
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, Awareness, Treatment, Control, and Correlates of Hypertension in the Pars Cohort Study.
Gandomkar A; Poustchi H; Malekzadeh F; Malekzadeh MM; Moini M; Moghadami M; Imanieh H; Fattahi MR; Sagheb MM; Ayatollahi SMT; Sepanlou SG; Malekzadeh R
Arch Iran Med; 2018 Aug; 21(8):335-343. PubMed ID: 30113854
[TBL] [Abstract][Full Text] [Related]
7. Alarm of non-communicable disease in Iran: Kavar cohort profile, baseline and 18-month follow up results from a prospective population-based study in urban area.
Safarpour AR; Fattahi MR; Niknam R; Tarkesh F; Mohammadkarimi V; Boogar SS; Abbasi E; Abtahi F; Sivandzadeh GR; Ejtehadi F; Afshar M; Shamsnia SA; Niknejad N
PLoS One; 2022; 17(1):e0260227. PubMed ID: 35085244
[TBL] [Abstract][Full Text] [Related]
8. The PERSIAN Cohort: Providing the Evidence Needed for Healthcare Reform.
Eghtesad S; Mohammadi Z; Shayanrad A; Faramarzi E; Joukar F; Hamzeh B; Farjam M; Zare Sakhvidi MJ; Miri-Monjar M; Moosazadeh M; Hakimi H; Rahimi Kazerooni S; Cheraghian B; Ahmadi A; Nejatizadeh A; Mohebbi I; Pourfarzi F; Roozafzai F; Motamed-Gorji N; Montazeri SA; Masoudi S; Amin-Esmaeili M; Danaie N; Mirhafez SR; Hashemi H; Poustchi H; Malekzadeh R
Arch Iran Med; 2017 Nov; 20(11):691-695. PubMed ID: 29480734
[TBL] [Abstract][Full Text] [Related]
9. Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design.
Poustchi H; Eghtesad S; Kamangar F; Etemadi A; Keshtkar AA; Hekmatdoost A; Mohammadi Z; Mahmoudi Z; Shayanrad A; Roozafzai F; Sheikh M; Jalaeikhoo A; Somi MH; Mansour-Ghanaei F; Najafi F; Bahramali E; Mehrparvar A; Ansari-Moghaddam A; Enayati AA; Esmaeili Nadimi A; Rezaianzadeh A; Saki N; Alipour F; Kelishadi R; Rahimi-Movaghar A; Aminisani N; Boffetta P; Malekzadeh R
Am J Epidemiol; 2018 Apr; 187(4):647-655. PubMed ID: 29145581
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of self-reported coronary heart disease and its associated risk factors in Tabari cohort population.
Ghaemian A; Nabati M; Saeedi M; Kheradmand M; Moosazadeh M
BMC Cardiovasc Disord; 2020 May; 20(1):238. PubMed ID: 32429905
[TBL] [Abstract][Full Text] [Related]
11. The Dehgolan Prospective Cohort Study (DehPCS) on non-communicable diseases in a Kurdish community in the west of Iran.
Moradpour F; Ghaderi E; Moradi G; Zarei M; Bolbanabad AM; Piroozi B; Shokri A
Epidemiol Health; 2021; 43():e2021075. PubMed ID: 34607397
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study.
Farzadfar F; Murray CJ; Gakidou E; Bossert T; Namdaritabar H; Alikhani S; Moradi G; Delavari A; Jamshidi H; Ezzati M
Lancet; 2012 Jan; 379(9810):47-54. PubMed ID: 22169105
[TBL] [Abstract][Full Text] [Related]
13. The burden and predisposing factors of non-communicable diseases in Mashhad University of Medical Sciences personnel: a prospective 15-year organizational cohort study protocol and baseline assessment.
Tohidinezhad F; Khorsand A; Zakavi SR; Rezvani R; Zarei-Ghanavati S; Abrishami M; Moradi A; Tavakoli M; Farrokh D; Rad MP; Abbasi B; Ahadi M; Saleh LA; Tayebi M; Amini M; Poustchi H; Abu-Hanna A; Eslami S
BMC Public Health; 2020 Nov; 20(1):1637. PubMed ID: 33138802
[TBL] [Abstract][Full Text] [Related]
14. Cohort profile: Bandar Kong prospective study of chronic non-communicable diseases.
Nejatizadeh A; Eftekhar E; Shekari M; Farshidi H; Davoodi SH; Shahmoradi M; Poustchi H; Ghanbarnejad A; Aghamolaei T; Yousefi H; Rafati S
PLoS One; 2022; 17(5):e0265388. PubMed ID: 35550629
[TBL] [Abstract][Full Text] [Related]
15. Non-communicable diseases in older people living with HIV in four African countries: a cohort study.
Chang D; Esber A; Dear N; Iroezindu M; Bahemana E; Kibuuka H; Owuoth J; Maswai J; Crowell T; Polyak C; Cavanaugh JS; Ake JA; Godfrey C
Lancet HIV; 2022 Mar; 9 Suppl 1():S5. PubMed ID: 35304847
[TBL] [Abstract][Full Text] [Related]
16. Burden of cumulative risk factors associated with non-communicable diseases among adults in Uganda: evidence from a national baseline survey.
Wesonga R; Guwatudde D; Bahendeka SK; Mutungi G; Nabugoomu F; Muwonge J
Int J Equity Health; 2016 Dec; 15(1):195. PubMed ID: 27905949
[TBL] [Abstract][Full Text] [Related]
17. Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results.
Gandomkar A; Poustchi H; Moini M; Moghadami M; Imanieh H; Fattahi MR; Ayatollahi SM; Sagheb MM; Anushiravani A; Mortazavi R; Sepanlou SG; Malekzadeh R
Int J Public Health; 2017 Apr; 62(3):397-406. PubMed ID: 27349480
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic Profile of Hypertension in Northern Iranian Population: The PERSIAN Guilan Cohort Study (PGCS).
Naghipour M; Joukar F; Salari A; Asgharnezhad M; Hassanipour S; Mansour-Ghanaei F
Ann Glob Health; 2021 Feb; 87(1):14. PubMed ID: 33614420
[TBL] [Abstract][Full Text] [Related]
19. Kharameh cohort study (KHCS) on non-communicable diseases and preliminary findings of 3-year follow-up.
Rezaianzadeh A; Niazkar HR; Rezaeianzadeh R; Jafari F; Rahimikazerooni S; Ghoddusi Johari M; Zare M; Hosseini SV
BMJ Open; 2024 Feb; 14(2):e077116. PubMed ID: 38331866
[TBL] [Abstract][Full Text] [Related]
20. The burden of non-communicable diseases and their related risk factors in the country of Georgia, 2015.
Russell S; Sturua L; Li C; Morgan J; Topuridze M; Blanton C; Hagan L; Salyer SJ
BMC Public Health; 2019 May; 19(Suppl 3):479. PubMed ID: 32326912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
